Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Page 1
Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatement.
Neuropharmacology. 2023 Nov 15;239:109685. doi: 10.1016/j.neuropharm.2023.109685. Epub 2023 Aug 12.
Neuropharmacology. 2023.
PMID: 37579870
ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seeking.
Illenberger JM, Flores-Ramirez FJ, Matzeu A, Lütjens R, Martin-Fardon R.
Illenberger JM, et al.
Neuropharmacology. 2023 Nov 1;238:109666. doi: 10.1016/j.neuropharm.2023.109666. Epub 2023 Jul 16.
Neuropharmacology. 2023.
PMID: 37463637
Item in Clipboard
Strain and sex-related behavioral variability of oxycodone dependence in rats.
Doyle MR, Martinez AR, Qiao R, Dirik S, Di Ottavio F, Pascasio G, Martin-Fardon R, Benner C, George O, Telese F, de Guglielmo G.
Doyle MR, et al.
Neuropharmacology. 2023 Oct 1;237:109635. doi: 10.1016/j.neuropharm.2023.109635. Epub 2023 Jun 15.
Neuropharmacology. 2023.
PMID: 37327971
Free PMC article.
Item in Clipboard
Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats.
Illenberger JM, Flores-Ramirez FJ, Matzeu A, Mason BJ, Martin-Fardon R.
Illenberger JM, et al.
Front Pharmacol. 2023 Apr 27;14:1127735. doi: 10.3389/fphar.2023.1127735. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37180716
Free PMC article.
Item in Clipboard
Cite
Cite